FAQ
How sure am I to get a proper injection when I use a NovoFine® 6mm x 31G needle?
Insulin injection should be targeted at the subcutaneous skin layer to get a predictable and reproducible insulin absorption. Since the thickness of the skin varies between 1-4 mm around the body, a 6mm needle with 90 degree injection angle (recommended without skin fold if injecting into abdomen, with lifted skin fold for all other injection sites) is ideal for proper insulin injection.
Can obese people use the shorter NovoFine® needles?
Obese people have the same skin thickness as everybody else, so the shorter needles are just as suitable for obese people (recommended with lifted skin fold at thigh, without skin fold at abdomen).
Why does Novo Nordisk recommend against re-using NovoFine® needles?
Re-using needles could increase the risk of injection pain, tissue damage, infection, increased insulin flow resistance, insulin leaks and lipohypertrophy.
What is the correct injection method for each of the NovoFine® needles for different types of patients?
Answer 1: NovoFine® 6mm x 31G: Perpendicular insertion, skin fold for slim and normal weight children, slim and normal adults, and higher weight adolescents. Perpendicular insertion without skin fold for obese persons and persons unable or unwilling to use a skin fold.
Answer 2: NovoFine® 8mm x 30G: 45 degree angle of insertion, skin fold for slim and normal weight children and slim adults. Perpendicular insertion with skin fold for normal and higher weight adolescents and obese persons.
Answer 3: NovoFine® 12mm x 28G: 45 degree angle of insertion, skin fold for persons presently using 12mm needles without clinical indication that they would benefit from a shorter needle length.
